{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:13:04Z","timestamp":1784027584787,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11239-020-02346-7","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T08:02:43Z","timestamp":1606550563000},"page":"711-719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5500-969X","authenticated-orcid":false,"given":"Claire","family":"Pluchart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gael","family":"Poitevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Audonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,28]]},"reference":[{"key":"2346_CR1","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","volume":"33","author":"C-H Pui","year":"2015","unstructured":"Pui C-H, Yang JJ, Hunger SP et al (2015) Childhood acute lymphoblastic leukemia: progress through collaboration. JCO 33:2938\u20132948. https:\/\/doi.org\/10.1200\/JCO.2014.59.1636","journal-title":"JCO"},{"key":"2346_CR2","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3324\/haematol.2017.165845","volume":"102","author":"V Mondelaers","year":"2017","unstructured":"Mondelaers V, Suciu S, De Moerloose B et al (2017) Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951. Haematologica 102:1727\u20131738. https:\/\/doi.org\/10.3324\/haematol.2017.165845","journal-title":"Haematologica"},{"key":"2346_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/jth.13236","volume":"14","author":"R Tuckuviene","year":"2016","unstructured":"Tuckuviene R, Ranta S, Albertsen BK et al (2016) Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study. J Thromb Haemost 14:485\u2013494. https:\/\/doi.org\/10.1111\/jth.13236","journal-title":"J Thromb Haemost"},{"key":"2346_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/asheducation-2017.1.251","volume":"2017","author":"R Hough","year":"2017","unstructured":"Hough R, Vora A (2017) Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment). Hematology Am Soc Hematol Educ Program 2017:251\u2013258. https:\/\/doi.org\/10.1182\/asheducation-2017.1.251","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"Suppl 1","key":"2346_CR5","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.thromres.2018.01.019","volume":"164","author":"S Levy-Mendelovich","year":"2018","unstructured":"Levy-Mendelovich S, Barg AA, Kenet G (2018) Thrombosis in pediatric patients with leukemia. Thromb Res 164(Suppl 1):S94\u2013S97. https:\/\/doi.org\/10.1016\/j.thromres.2018.01.019","journal-title":"Thromb Res"},{"key":"2346_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1055\/s-0034-1370795","volume":"40","author":"CH van Ommen","year":"2014","unstructured":"van Ommen CH, Chan AKC (2014) Supportive care in pediatric cancer: the road to prevention of thrombosis. Semin Thromb Hemost 40:371\u2013381. https:\/\/doi.org\/10.1055\/s-0034-1370795","journal-title":"Semin Thromb Hemost"},{"key":"2346_CR7","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1182\/blood-2010-01-263012","volume":"115","author":"L Mitchell","year":"2010","unstructured":"Mitchell L, Lambers M, Flege S et al (2010) Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood 115:4999\u20135004. https:\/\/doi.org\/10.1182\/blood-2010-01-263012","journal-title":"Blood"},{"key":"2346_CR8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.194175","author":"J Greiner","year":"2018","unstructured":"Greiner J, Schrappe M, Claviez A et al (2018) THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during inudction therapy of acute lymphoblastic leukemia in children and adolescents. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2018.194175","journal-title":"Haematologica"},{"key":"2346_CR9","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1182\/blood-2018-01-827949","volume":"131","author":"CU Rank","year":"2018","unstructured":"Rank CU, Toft N, Tuckuviene R et al (2018) Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years. Blood 131:2475\u20132484. https:\/\/doi.org\/10.1182\/blood-2018-01-827949","journal-title":"Blood"},{"key":"2346_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2141.2010.08524.x","volume":"152","author":"RF Grace","year":"2011","unstructured":"Grace RF, Dahlberg SE, Neuberg D et al (2011) The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. Br J Haematol 152:452\u2013459. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08524.x","journal-title":"Br J Haematol"},{"key":"2346_CR11","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1111\/jth.13871","volume":"15","author":"K Date","year":"2017","unstructured":"Date K, Ettelaie C, Maraveyas A (2017) Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer. J Thromb Haemost 15:2289\u20132299. https:\/\/doi.org\/10.1111\/jth.13871","journal-title":"J Thromb Haemost"},{"key":"2346_CR12","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3389\/fimmu.2018.01486","volume":"9","author":"S Caruso","year":"2018","unstructured":"Caruso S, Poon IKH (2018) Apoptotic Cell-Derived Extracellular Vesicles: More Than Just Debris. Front Immunol 9:1486. https:\/\/doi.org\/10.3389\/fimmu.2018.01486","journal-title":"Front Immunol"},{"key":"2346_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.thromres.2011.06.022","volume":"129","author":"JC Boles","year":"2012","unstructured":"Boles JC, Williams JC, Hollingsworth RM et al (2012) Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity. Thromb Res 129:197\u2013203. https:\/\/doi.org\/10.1016\/j.thromres.2011.06.022","journal-title":"Thromb Res"},{"key":"2346_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s11239-016-1471-z","volume":"43","author":"D Gheldof","year":"2017","unstructured":"Gheldof D, Haguet H, Dogn\u00e9 J-M et al (2017) Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia. J Thromb Thrombolysis 43:224\u2013232. https:\/\/doi.org\/10.1007\/s11239-016-1471-z","journal-title":"J Thromb Thrombolysis"},{"key":"2346_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jcp.2003.011643","volume":"57","author":"S Sava\u015fan","year":"2004","unstructured":"Sava\u015fan S, B\u00fcy\u00fckavci M, Buck S, Ravindranath Y (2004) Leukaemia\/lymphoma cell microparticles in childhood mature B cell neoplasms. J Clin Pathol 57:651\u2013653","journal-title":"J Clin Pathol"},{"key":"2346_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2015-12-688051","volume":"128","author":"SM Johnson","year":"2016","unstructured":"Johnson SM, Dempsey C, Chadwick A et al (2016) Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia. Blood 128:453\u2013456. https:\/\/doi.org\/10.1182\/blood-2015-12-688051","journal-title":"Blood"},{"key":"2346_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/leu.2016.217","volume":"31","author":"J Boysen","year":"2017","unstructured":"Boysen J, Nelson M, Magzoub G et al (2017) Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression. Leukemia 31:350\u2013360. https:\/\/doi.org\/10.1038\/leu.2016.217","journal-title":"Leukemia"},{"key":"2346_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3892\/mco.2017.1482","volume":"8","author":"LFB Fernandes","year":"2018","unstructured":"Fernandes LFB, Fregnani JHTG, Strunz CMC et al (2018) Role of P-selectin in thromboembolic events in patients with cancer. Mol Clin Oncol 8:188\u2013196. https:\/\/doi.org\/10.3892\/mco.2017.1482","journal-title":"Mol Clin Oncol"},{"key":"2346_CR19","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","volume":"130","author":"Y Hisada","year":"2017","unstructured":"Hisada Y, Mackman N (2017) Cancer-associated pathways and biomarkers of venous thrombosis. Blood 130:1499\u20131506. https:\/\/doi.org\/10.1182\/blood-2017-03-743211","journal-title":"Blood"},{"key":"2346_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/cyto.a.22685","volume":"89","author":"P Poncelet","year":"2016","unstructured":"Poncelet P, Robert S, Bouriche T et al (2016) Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: forward or side scatter? Cytometry A 89:148\u2013158. https:\/\/doi.org\/10.1002\/cyto.a.22685","journal-title":"Cytometry A"},{"key":"2346_CR21","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1111\/j.1538-7836.2010.03936.x","volume":"8","author":"W Cuccuini","year":"2010","unstructured":"Cuccuini W, Poitevin S, Poitevin G et al (2010) Tissue factor up-regulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony-forming cells without influencing non-coagulant properties in vitro. J Thromb Haemost 8:2042\u20132052. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03936.x","journal-title":"J Thromb Haemost"},{"key":"2346_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11239-019-01894-x","volume":"48","author":"C Pluchart","year":"2019","unstructured":"Pluchart C, Poitevin G, Colinart-Thomas M et al (2019) Vincristine induces procoagulant activity of the human lymphoblastic leukemia cell line Jurkat through the release of extracellular vesicles. J Thromb Thrombolysis 48:195\u2013202. https:\/\/doi.org\/10.1007\/s11239-019-01894-x","journal-title":"J Thromb Thrombolysis"},{"key":"2346_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000073575","volume":"32","author":"HC Hemker","year":"2002","unstructured":"Hemker HC, Giesen P, AlDieri R et al (2002) The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32:249\u2013253. https:\/\/doi.org\/10.1159\/000073575","journal-title":"Pathophysiol Haemost Thromb"},{"key":"2346_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/pbc.26228","volume":"64","author":"L Rozen","year":"2017","unstructured":"Rozen L, Noubouossie D, Dedeken L et al (2017) Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: a cohort study. Pediatr Blood Cancer 64:294\u2013301. https:\/\/doi.org\/10.1002\/pbc.26228","journal-title":"Pediatr Blood Cancer"},{"key":"2346_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/MBC.0b013e32834fb539","volume":"23","author":"K Lejhancova-Tousovska","year":"2012","unstructured":"Lejhancova-Tousovska K, Zapletal O, Vytiskova S et al (2012) Profile of thrombin generation in children with acute lymphoblastic leukemia treated by Berlin-Frankfurt-M\u00fcnster (BFM) protocols. Blood Coagul Fibrinolysis 23:144\u2013154. https:\/\/doi.org\/10.1097\/MBC.0b013e32834fb539","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2346_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ajh.23590","volume":"89","author":"M Marchetti","year":"2014","unstructured":"Marchetti M, Tartari CJ, Russo L et al (2014) Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia. Am J Hematol 89:68\u201373. https:\/\/doi.org\/10.1002\/ajh.23590","journal-title":"Am J Hematol"},{"key":"2346_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ajh.23553","volume":"88","author":"I Mignon","year":"2013","unstructured":"Mignon I, Grand F, Boyer F et al (2013) Thrombin generation and procoagulant phospholipids in patients with essential thrombocythemia and reactive thrombocytosis. Am J Hematol 88:1007\u20131011. https:\/\/doi.org\/10.1002\/ajh.23553","journal-title":"Am J Hematol"},{"key":"2346_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1538-7933.2004.00618.x","volume":"2","author":"K Vanschoonbeek","year":"2004","unstructured":"Vanschoonbeek K, Feijge MH, Van Kampen RJW et al (2004) Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2:476\u2013484. https:\/\/doi.org\/10.1111\/j.1538-7933.2004.00618.x","journal-title":"J Thromb Haemost"},{"key":"2346_CR29","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.3324\/haematol.2016.144279","volume":"101","author":"A Charpentier","year":"2016","unstructured":"Charpentier A, Lebreton A, Rauch A et al (2016) Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia. Haematologica 101:e365-368. https:\/\/doi.org\/10.3324\/haematol.2016.144279","journal-title":"Haematologica"},{"key":"2346_CR30","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1182\/blood-2008-06-163832","volume":"113","author":"R Flaumenhaft","year":"2009","unstructured":"Flaumenhaft R, Dilks JR, Richardson J et al (2009) Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 113:1112\u20131121. https:\/\/doi.org\/10.1182\/blood-2008-06-163832","journal-title":"Blood"},{"key":"2346_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ajh.21338","volume":"84","author":"E Arellano-Rodrigo","year":"2009","unstructured":"Arellano-Rodrigo E, Alvarez-Larr\u00e1n A, Reverter J-C et al (2009) Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden. Am J Hematol 84:102\u2013108. https:\/\/doi.org\/10.1002\/ajh.21338","journal-title":"Am J Hematol"},{"key":"2346_CR32","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E et al (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902\u20134907. https:\/\/doi.org\/10.1182\/blood-2007-10-116327","journal-title":"Blood"},{"key":"2346_CR33","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","volume":"116","author":"C Ay","year":"2010","unstructured":"Ay C, Dunkler D, Marosi C et al (2010) Prediction of venous thromboembolism in cancer patients. Blood 116:5377\u20135382. https:\/\/doi.org\/10.1182\/blood-2010-02-270116","journal-title":"Blood"},{"key":"2346_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12959-019-0202-z","volume":"17","author":"A-S Mirza","year":"2019","unstructured":"Mirza A-S, Yun S, Ali NA et al (2019) Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience. Thromb J 17:13. https:\/\/doi.org\/10.1186\/s12959-019-0202-z","journal-title":"Thromb J"},{"key":"2346_CR35","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","volume":"108","author":"V Caruso","year":"2006","unstructured":"Caruso V, Iacoviello L, Di Castelnuovo A et al (2006) Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 108:2216\u20132222. https:\/\/doi.org\/10.1182\/blood-2006-04-015511","journal-title":"Blood"},{"key":"2346_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/08880010050211376","volume":"17","author":"P Giordano","year":"2000","unstructured":"Giordano P, Del Vecchio GC, Santoro N et al (2000) Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups. Pediatr Hematol Oncol 17:667\u2013672","journal-title":"Pediatr Hematol Oncol"},{"key":"2346_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3324\/haematol.2012.073601","volume":"98","author":"S Bloemen","year":"2013","unstructured":"Bloemen S, Hemker HC, Al Dieri R (2013) Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation. Haematologica 98:549\u2013554. https:\/\/doi.org\/10.3324\/haematol.2012.073601","journal-title":"Haematologica"},{"key":"2346_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","volume":"376","author":"KI Ataga","year":"2017","unstructured":"Ataga KI, Kutlar A, Kanter J et al (2017) Crizanlizumab for the prevention of pain crises in sickle cell disease. N Engl J Med 376:429\u2013439. https:\/\/doi.org\/10.1056\/NEJMoa1611770","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02346-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T10:58:51Z","timestamp":1618484331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02346-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02346-7","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,28]]},"assertion":[{"value":"16 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}